Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Prestige Brand Holdings (PBH)

Prestige Brand Holdings (PBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Prestige Brand Holdings 660 WHITE PLAINS ROAD TARRYTOWN NY 10591 USA

www.prestigebrands.com P: 914-524-6800

Description:

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.

Key Statistics

Overview:

Market Capitalization, $K 3,482,380
Enterprise Value, $K 4,769,681
Shares Outstanding, K 49,649
Annual Sales, $ 1,128 M
Annual Net Income, $ -82,310 K
Last Quarter Sales, $ 282,740 K
Last Quarter Net Income, $ 53,050 K
EBIT, $ 372,370 K
EBITDA, $ 409,360 K
60-Month Beta 0.52
% of Insider Shareholders 1.60%
% of Institutional Shareholders 99.95%
Float, K 48,855
% Float 98.40%
Short Volume Ratio 0.50

Growth:

1-Year Return 15.35%
3-Year Return 61.02%
5-Year Return 136.16%
5-Year Revenue Growth 8.31%
5-Year Earnings Growth 63.18%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.06 on 02/08/24
Latest Earnings Date 05/02/24 [--]
Earnings Per Share ttm 4.26
EPS Growth vs. Prev Qtr -0.93%
EPS Growth vs. Prev Year 1.92%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.475 on 09/27/18
Next Ex-Dividends Date 09/27/18
Dividend Payable Date 10/15/18
Dividend Payout Ratio 0.00%

PBH Ratios

Ratio
Price/Earnings ttm 16.46
Price/Earnings forward 15.45
Price/Earnings to Growth 1.93
Return-on-Equity % 14.09%
Return-on-Assets % 6.39%
Profit Margin % -7.30%
Debt/Equity 0.75
Price/Sales 3.08
Price/Cash Flow 14.21
Price/Book 2.21
Book Value/Share 32.26
Interest Coverage -0.36

PBH Dividends

Date Value
09/27/18 $0.4750
03/29/11 $0.2940
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar